GLP-1 weight loss users cut food spending in their first 3 months, says Circana. But by the end of year one, spending is ...
Experimental weight-loss drug Retatrutide shows promise, helping obese adults lose up to 22% of their weight in 48 weeks.
New anti-obesity drugs should meet a minimum level of weight loss to be considered for approval, the FDA said ...
In 2025, health trends spotlight polyphenols as natural weight-loss aids and fiber for longevity. Nutritionists recommend polyphenol-rich foods and fiber boosts to improve vitality, reducing premature ...
January is often a time for setting health goals, with weight loss topping many New Year’s resolutions. As people explore the best path forward, they may encounter a variety of ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no signs of slowing down, much to the delight of its Danish manufacturer, Novo ...
People are losing much more than fat.
It’s January, which is typically when many of us are looking into shedding some pounds. We’ve been hearing a lot about how ...
What does the latest science say about the use of GLP-1 meds to treat obesity in people without diabetes?A review of 26 ...
Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...
Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback